CuraMe
Pitch · May 2026 · Confidential
Italian primary care · The operational layer

Italian primary care is breaking.
We're building the layer that holds it together.

CuraMe is the AI-powered operational co-pilot for Italian general practitioners. SegretAI drafts. The doctor decides. 25 hours per month recovered from administrative work — at €30 per month.

SegretAI
EU-resident
Human-in-loop
5,000+ GPs · Y2
CuraMe
Scroll
A scenario

Consider one Italian general practitioner.

Forty-eight years old. Lombardy. Twenty-two years of practice. Eight in the same office. Today she opens her laptop at 7:48 in the morning.

Her caseload

She has 1,500 patients on paper. 1,820 in practice.

The 1,500-patient ceiling was created to protect care quality. It is now routinely waived so the system doesn't collapse.

The new shape of the work

The visits are not the bottleneck.

Forty messages a day. Prescription requests. Referral letters. Reports to summarise. Lab results to communicate. WhatsApp. Email. Phone. Different channels. Same patient. No single inbox.

The math, plainly

Four hours a day, not being a doctor.

Across the country, this scales to a labor shortage no replacement pipeline can fill. The workforce isn't growing; the demand is. The curves crossed five years ago.

The hypothesis

Restore the bottleneck. Give back the hours.

An operational co-pilot that drafts the asynchronous, ingests the documents, holds the continuity — and lets the physician do what only the physician can do.

1,820
Doctor
§ 01 · The problem

The math of Italian general practice no longer works.

Italy has the second-oldest population in Europe and one of the highest demand pressures on primary care. It also has a contracting GP workforce. These two curves crossed five years ago. They will not uncross before 2030. This is not a cyclical problem.

0
General practitioners missing from the Italian national system today.
GIMBE 2024
0%
of practicing GPs are above the 1,500-patient regulatory cap.
FIMMG · Ministry of Health
0%
of the Italian population is over 65, with chronic-care needs concentrated.
ISTAT 2024
§ 02 · A doctor's day

Drag the line. See the same morning, two ways.

Same patient inbox at 8:14 AM. Same forty messages. On the left, the world a GP knows in 2026 — fragmented channels, parallel queues, no continuity. On the right, the same workload through CuraMe — unified, drafted, audit-logged.

Without CuraMe · today
WhatsApp"Dottoressa, ricetta urgente?"
EmailReferto cardiologo allegato.pdf
SMS"Ho ancora la tosse"
PhoneVoicemail 02:14 · Maria R.
WhatsApp"Posso il vaccino?"
EmailEsami sangue · Antonio B.
SMS"Quando posso passare?"
WhatsApp"Mi serve impegnativa"
PhoneMissed call · Lucia C.
~4h spent on admin · daily
With CuraMe · today
8:14Maria R.draft readyai
8:22Antonio B.prescription draftedai
8:31Lucia C.vaccine slot offeredai
8:38Giuseppe P.referral routedai
8:44Sara M.follow-up scheduledai
8:51Roberto T.cardio report readai
8:57Elena C.screening reminderai
~30min spent reviewing · same workload
§ 03 · Live demonstration

This is what actually happens in the GP's day.

A patient writes. SegretAI prepares a complete draft, including the appropriate clinical detail and the GP's own tone profile. The doctor edits if needed, then sends. Every action is logged. Every clinical decision remains the physician's.

pro.curamesalute.it · Inbox
Inbox 12
Documents 3
Prescriptions 7
Follow-ups 5
MR
Maria R.
8:14 AM
Buongiorno dottoressa, ieri ho ritirato gli esami del sangue. Posso averli interpretati? Grazie.
SegretAI · Drafting
SegretAI is drafting reply
AI draft acceptance rate
82%
Median draft time
3.4s
Audit-log coverage
100%
§ 04 · The product

Two products.
One operating layer.

CuraMe is not a marketplace. Not a telemedicine app. Not an AI scribe. It is the daily-workflow co-pilot that lets an Italian GP and their patients stay continuously connected — without either of them changing how they work.

For the doctor

CuraMe Pro

  • Unified inbox for patient messages, documents, requests
  • AI-drafted replies — every one reviewed before sending
  • Document handling: OCR, tagging, auto-attach to record
  • Follow-up engine for chronic care and prevention
  • Audit log on every AI action

SegretAI

The orchestration layer between patient and doctor.

For the patient

CuraMe app

  • Structured symptom check-in before messaging the GP
  • Personal health record — visits, prescriptions, exams
  • Reminders for screening, vaccinations, prevention
  • Reliable, physician-vetted health content
  • Direct async chat with the GP — no marketplace
§ 05 · The economics, made tangible

Move the sliders. Watch a GP's month change.

These are not marketing numbers. They are derived from time-and-motion observations on the first 50 GPs using CuraMe in real practice. Adjust the assumptions to your own scenario.

1,500
40
22
1.7
Hours recovered / month 25 Direct administrative time given back to the physician.
Monetary value / month €2,119 Avg. €85/hr clinical-time value + reduced secretarial cost. Conservative.
ROI on €30 / month subscription 71× For every euro spent on CuraMe, the GP gets multiples back in recovered time.
§ 06 · For investors

Why this isn't another SaaS feature.

The fair objection in 2026: in an age of general-purpose AI, what makes CuraMe defensible? The answer is that the binding constraints in Italian primary care are not technological. They are trust, regulation, language, and embedded workflow. Click each card to dig deeper.

i

Distribution.

Italian GPs adopt tools through associations, peer networks, and accredited CME — not paid ads.

Three trust channels compound: FIMMG/SNAMI partnerships, ECM-accredited CME programs, and province-level peer-referral. A horizontal AI competitor would need 18+ months and a dedicated medical-affairs team to replicate this access. We already have it.
Read more
ii

Workflow.

Embedded in the daily inbox via PMS integrations. Switching cost is measured in lost time.

Once SegretAI is drafting the daily replies and CuraMe is the unified inbox, removing it means re-fragmenting WhatsApp + email + phone. The cost is not the €30/month subscription; it's the 25 hours/month the GP loses by leaving. Embedded software gets extended, not replaced.
Read more
iii

Regulation.

EU residency, GDPR Art.9, AI Act human-in-the-loop by design. 6–9 months of compliance engineering.

Italian health data is special-category under GDPR Art. 9, governed by Garante guidance, AGID's CAD, and the EU AI Act high-risk classification. CuraMe is built for this stack from inception. A US- or UK-based consumer AI cannot lawfully replicate this without substantial re-engineering.
Read more
iv

Data flywheel.

Italian GP–patient interactions are a corpus no foundation model has and cannot acquire.

Every interaction processed through SegretAI generates structured, anonymised, GP-specific signal: the language Italian patients use, the templates GPs accept, the clinical conventions of Italian primary care. Over 24 months this becomes the basis for accuracy no generalist model can match without operating the product.
Read more
v

Two-sided lock-in.

Patient brings retention pressure on the GP; GP brings credibility on the patient.

Single-sided competitors face a cold-start problem on whichever side they begin. CuraMe operates both. Once a patient has a longitudinal record in CuraMe and an active link to their GP, the GP cannot leave without losing the patient experience — and the patient cannot leave without losing the doctor relationship.
Read more
§ 06 · For partners and stakeholders

Three commitments that do not change as the company scales.

i

The physician is always in the loop.

CuraMe drafts; the doctor decides. We will not ship features that bypass clinical judgement, regardless of what becomes technically possible.

ii

Patient data belongs to the patient.

Custodianship, not ownership. Portability and deletion are first-class product features, not afterthoughts.

iii

Adoption is earned, not bought.

No dark patterns, no engagement-maxing nudges. If a feature doesn't recover GP time or improve patient continuity, it doesn't ship.

§ 07 · The opportunity

Italy first.
Europe by extension.

Italy is acute today. France, Spain, and Germany are 3–5 years behind on the same curve. Five priority regions concentrate 45% of our serviceable addressable market. Hover the map.

LO VE ER LZ PU
TAM · Italian primary care
37,800 GPs × full subscription value (GP + patient blended)
€73M
SAM · Digital-receptive segment
Tech-adopting GPs across urban and suburban Italy
€40M
SOM · Y2 (2027)
Realistic 24-month penetration of the SAM
€5.2M
SOM · Y5 (2030)
Italian leadership scenario · pre-EU expansion
€12.7M
§ 08 · Traction

Live in production. Paying. Growing.

Not a pitch deck. Real GPs running real practices with CuraMe inside their daily workflow today. The first cohort behaves like the model expects — only better on the churn axis.

0
Paying GPs onboarded
0
Active patients
0+
AI-drafted interactions
1.9%
Monthly gross churn · vs 3.5% benchmark

Paying-GP growth projection

Base case · Investment-secured
Today50 Y1 · 2026385 Y2 · 20275,285 Y3 · 20289,500 Y5 · 203018,000
§ 09 · Who builds this

Two founders.
Five advisors. One mission.

CEO & Co-Founder

Davide Ricciardi

Commercial & growth background in digital health and fintech. Runs the commercial engine and the founder-led onboarding of the first 50 GPs.

CTO & Co-Founder

Egidio Salinaro

Owns the entire technical stack — GP web app, patient mobile app, SegretAI orchestrator, EU-resident compliance architecture.

Five strategic advisors, each anchored to a specific domain.
Dino TreccaMarketing · Medical network
Mohit SundaDevelopment
Raffaele RattiniFinance
Michele PozzoAI · GDPR
Simone ZanniDevelopment
§ 10 · The round
§ 10 · Where we are headed

€500k pre-seed.
24 months of runway.

By 2030, the operating layer of European primary care.

Round size
€500k
Runway
24 mo
Next round target
Series A
Instrument
SAFE/Equity

Let's continue
this conversation.

The pitch is a starting point — not an ending. We want investors and partners who will challenge assumptions, push back on the model, and ask the awkward questions. Reach out.